Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Non-Current Assets of $504.9 million for Q4 2025, up 643545.94% year-over-year from N/an in Q4 2024, and up 0.96% on a QoQ basis from $500.1 million in Q3 2025.
Drugs Made In America Acquisition (DMII) has 2 years of Non-Current Assets data on file, last reported at $504.9 million in Q4 2025.
- Quarterly Non-Current Assets rose 643545.94% year-over-year to $504.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $504.9 million (up 643545.94% YoY) and the FY2025 annual result came in at $504.9 million, up 643545.94% from the prior year.
- Non-Current Assets advanced to $504.9 million in Q4 2025 per DMII's latest filing, from $500.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $504.9 million in Q4 2025 and bottomed at $78449.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 472.84 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 311.36 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 310.90 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 310.26 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 365.97 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 288.44 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 272.15 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 285.88 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 261.51 Mn |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | 504.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.93 Mn |
| Sep 30, 2025 | 500.11 Mn |
| Dec 31, 2024 | 78,449.00 |